Renato Skerlj, based in Waltham, MA, US, is currently a Chief Executive Officer at Expansion Therapeutics, bringing experience from previous roles at X4 Pharmaceuticals and Drug Discovery Consulting LLC. Renato Skerlj holds a 1984 - 1988 PhD in Synthetic Organic Chemistry, Ed Piers @ The University of British Columbia. With a robust skill set that includes Medicinal Chemistry, Biotechnology, Chemistry, Cancer, Small Molecules and more, Renato Skerlj contributes valuable insights to the industry. Renato Skerlj has 5 emails on RocketReach.